Physician profile
Denise E Joseph
NPI 1922197995
$2,327.09
in general payments reported to CMS, 2019-2025
13 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $218 · 2021: $510 · 2022: $695 · 2023: $31.65 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $504.41 | 2019-2025 | Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $359.19 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $327.17 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $296.98 | 2021-2025 | |
| Alkermes, INC. | $209.95 | 2020-2022 | |
| Indivior INC. | $156.07 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $123.97 | 2019-2021 | |
| Abbvie INC. | $86.10 | 2021-2023 | |
| Lundbeck LLC | $81.83 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $71.27 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $69.45 | 2019 | |
| Harmony Biosciences LLC | $27.84 | 2022 | |
| Allergan, INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.